In other words, ‘98% sensitivity’ indicates that 489 out of 499 (98%) subjects with clinically significant prostate cancer were correctly identified as positive using a PSA density cutoff ≥0.08 ng/mL/cc. This evidence concerns the gene KLK3 and Familial prostate cancer.